Medicine
Short Ragweed 1 g/10 mL injection
Short Ragweed 1 g/10 mL injection is a prescription medicine containing Ambrosia artemisiifolia pollen for cutaneous, intradermal, subcutaneous use, marketed by Allermed Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Ambrosia artemisiifolia pollen
- Brand
- Short Ragweed
- Strength
- 1 g/10 mL
- Dosage form
- Injection
- Route
- Cutaneous, intradermal, subcutaneous
- Packs
- 10 mL
- Marketing authorisation holder
- Allermed Laboratories
- Manufacturer
- Allermed Laboratories
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 March 1982
- Identifiers
- RxCUI 896140DailyMed set ID 1482f8a2-c2c0-45a1-8e90-b427227f0b28NDC 49643-315Application BLA103113
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 mL in 1 vial, multi-dose | 49643-315-10 | Allermed Laboratories | 22 March 1982 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ambrosia artemisiifolia pollen
Clinical summary
Ambrosia artemisiifolia pollen is a standardized pollen allergenic extract. It is available as injection for cutaneous, intradermal and subcutaneous use. MedsAcross supplies Ambrosia artemisiifolia pollen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ambrosia artemisiifolia pollenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Short Ragweed prescribing information (Allermed Laboratories) · U.S. National Library of Medicine, DailyMed
Need Short Ragweed 1 g/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.